Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

5-hydroxytryptamine and precapillary vessels.

J M Van Nueten

    Federation Proceedings
    |February 1, 1983
    PubMed
    Summary

    5-hydroxytryptamine (5-HT) has complex vascular effects, acting differently on various arteries. Specific antagonists like ketanserin block 5-HT2 receptors, revealing its vasodilator actions and inhibiting platelet-induced contractions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Development of a new gastrointestinal prokinetic; pharmacology of cisapride].

    Journal de pharmacie de Belgique·1991
    Same author

    Effect of ridogrel on vascular contractions caused by vasoactive substances released during platelet activation.

    Thrombosis and haemostasis·1990
    Same author

    R 50 595, a selective non-competitive antagonist of cisapride, BRL 24924 and 5-hydroxytryptamine on the guinea-pig ileum.

    European journal of pharmacology·1990
    Same author

    Computer-assisted method for the analysis of postprandial gastrointestinal motility in conscious dogs.

    Medical & biological engineering & computing·1989
    Same author

    Nebivolol is devoid of intrinsic sympathomimetic activity.

    European journal of pharmacology·1989
    Same author

    [Pharmacology of drugs acting on gastrointestinal motility].

    Zeitschrift fur Gastroenterologie·1988

    Area of Science:

    • Pharmacology
    • Vascular Biology
    • Cardiovascular Research

    Background:

    • 5-hydroxytryptamine (5-HT) exhibits complex and varied vascular effects depending on the arterial tissue.
    • Its interaction with 5-HT2 receptors plays a crucial role in mediating these responses.
    • Endogenous 5-HT released from aggregating platelets contributes to vascular tone.

    Purpose of the Study:

    • To elucidate the complex vascular actions of 5-hydroxytryptamine (5-HT).
    • To investigate the role of 5-HT2 receptors and specific antagonists in modulating vascular responses.
    • To understand the amplifying effect of 5-HT on vasoconstriction.

    Main Methods:

    • Utilizing specific 5-HT2 receptor antagonists, such as ketanserin and methysergide.
    • Examining contractile responses to endogenous 5-HT released from aggregating platelets.
    • Assessing the vasodilator component of 5-HT responses under serotonergic blockade.
    • Investigating the amplification of vasoconstrictor responses by 5-HT.

    Main Results:

    • Vascular sensitivity to 5-HT differs across arterial tissues of diverse origins.
    • Ketanserin and methysergide effectively inhibit 5-HT interaction with 5-HT2 receptors and platelet-induced contractions.
    • The vasodilator effects of 5-HT can be isolated using specific antagonists lacking partial agonistic properties.
    • 5-HT amplifies vasoconstrictor responses to neurohumoral mediators, an effect blocked by 5-HT2 antagonists like ketanserin.

    Conclusions:

    • The vascular effects of 5-HT are complex and receptor-dependent.
    • 5-HT2 receptor antagonists are valuable tools for dissecting the distinct vascular actions of 5-HT.
    • 5-HT significantly modulates vascular reactivity, amplifying vasoconstrictor signals.

    Related Experiment Videos